Sponsor
Vividion Therapeutics Inc.
5820 Nancy Ridge Drive, 92121-2842, United States
About the sponsor
Vividion Therapeutics Inc. focuses on early clinical research in advanced solid tumours, with studies centred on safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumour activity. Its portfolio includes first-in-human evaluation of novel oncology agents in patients with refractory solid tumours.
- First-in-human oncology
- Anti-tumour activity
- Solid tumour malignancies
The sponsor’s work in this area extends across dose escalation and dose expansion settings, reflecting a strong interest in identifying therapeutic activity in difficult-to-treat tumour populations.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.